Skip to main content
Log in

Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

8-OH-DPAT (2.5–10 mg/kg) and buspirone (10 mg/kg) but not 5,7DHT (200 Μg/mouse), pCPA (75 and 150 mg/kg, three times), ritanserin (0.1 and 0.2 mg/kg), LY 53857 (1.5 and 3 mg/kg), GR 38032 F (0.1–100 Μg/kg), TFMPP (5 and 20 mg/kg) and mCPP (2.5 and 5 mg/kg) antagonized the rise in body temperature that occurs to the last mice removed from their group housing, which was termed as stress-induced hyperthermia (SIH). Ro 15-1788, at a dose which blocked the effect of diazepam on SIH, did not reverse the anxiolytic effect of buspirione. Instead, when cerebral 5-HT content was reduced to 50% by 5,7-DHT-induced lesion, the effect of buspirone on SIH was decreased. TFMPP 5 mg/kg did not shorten significantly the onset of SIH as could have been expected by an anxiogenic drug, while the dose of 20 mg/kg did not modify the pattern of SIH at all. The lower dose of TFMPP evoked a hyperthermic and the higher a hypothermic response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

TFMPP:

m-trifluoromethylphenylpiperazine

mCPP:

m-chlorophenylpiperazine

pCPA:

P-chlorophenylalanine

5,7 DHT:

5,7 dihydroxytryptamine

8-OH-DPAT:

8-hydroxy-2-(di-N-propylamino)tetralin

5-HT:

serotonin

References

  • Bonanno G, Maura G, Raiteri M (1986) Pharmacological characterization of releaseregulating serotonin autoreceptors in rat cerebellum. Eur J Pharmacol 126: 317–321

    Google Scholar 

  • Borsini F (1985) Randomization program for Apple IIe computer. Brain Res Bull 15: 279–281

    Google Scholar 

  • Borsini F, Lecci A, Volterra G, Meli A (1989) A model to measure anticipatory anxiety in mice? Psychopharmacology 98: 207–211

    Google Scholar 

  • Brittain RT, Butler A, Coates IH, Fortune DH, Hagan R, Hill JM, Humber DC, Humprey PPA, Ireland SJ, Jack DJ, Jordan CC, Oxford A, Straughan DW, Tyers MB (1987) GR 38032 F, a novel selective 5-HT3 receptor antagonist. Br J Pharmacol 90: 87 P

  • Carli M, Samanin R (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist. Psychopharmacology 94: 84–91

    Google Scholar 

  • Carli M, Prontera C, Samanin R (1989a) Effect of 5HT1A agonists of stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolyticlike activity. Neuropharmacology 28: 471–476

    Google Scholar 

  • Carli M, Prontera C, Samanin R (1989b) Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br J Pharmacol 96: 829–836

    Google Scholar 

  • Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healty subjects. Psychopharmacology 92: 14–24

    Google Scholar 

  • Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci 8: 383–388

    Google Scholar 

  • Cohen ML, Kurz KD, Mason NR, Fuller RW, Marzoni GP, Garbrecht WL (1985) Pharmacological activity of the isomers of LY 53857, potent and selective 5-HT 2 antagonist. J Pharmacol Exp Ther 235: 319–323

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1987) Releative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT 1c) receptors. J Pharmacol Exp Ther 242: 552–557

    Google Scholar 

  • Costall B, Kelly ME, Naylor RJ, Onaivi ES (1988) Actions of buspirone in a putative model of anxiety in the mouse. J Pharm Pharmacol 40: 494–500

    Google Scholar 

  • Critchley MAE, Handley SL (1987) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93: 502–506

    Google Scholar 

  • Critchley MAE, Njung' K, Handley SL (1988) Prevention of 8-OH-DPAT anxiogenic effects by ipsapirone and by 5-HT 1A antagonist Β-adrenoceptor antagonists. Br J Pharmacol 94: 389 P

  • Davis M, Cassella JV, Kehene JG (1988) Serotonin does not mediate anxiolytic effects of buspirone an fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Phsychopharmacology 94: 14–20

    Google Scholar 

  • Dourish CT, Hutson PH, Curzon G (1986) Putative anxiolytics 8-OH-DPAT, buspirone and TVXQ 7821 are agonist at 5-HT 1A autoreceptors in the raphe nuclei. Trends Pharmacol Sci 7: 212–214

    Google Scholar 

  • Eison AS, Davis MA, Temple JR (1986a) Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med 80 [Suppl 13B]: 1–9

    Google Scholar 

  • Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotoninergic mechanisms in the behavioural effects of buspirone e gepirone. Pharmacol Biochem Behav 24: 701–707

    Google Scholar 

  • Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrandt K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT 1B binding sites. Naunyn-Schmiedebergs Arch Pharmacol 332: 1–7

    Google Scholar 

  • Engel JA, Hjort S, Svensson K, Carlsson A, Liljequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hyroxypropylamino) tetralin (8-OH-DPAT). Eur J Pharmacol 105: 365–368

    Google Scholar 

  • File SE, Hyde JRG (1977) The effects of p-chlorophenylalanine and ethanolamine-Osulphate in an animal test of anxiety. J Pharm Pharmacol 29: 735–738

    Google Scholar 

  • File SE, Johnston AL, Pellow S (1987) Effects of compounds acting at CNS 5-hydroxytryptamine systems on anxiety in the rat. Br J Pharmacol 90: 265 P

  • File SE, Johnston AL (1989) Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in rats. Psychopharmacology 99: 248–251

    Google Scholar 

  • Frances H (1988) Psychopharmacological profile of 1-(m-(trifluoromethyl)phenyl)piperazine (TFMPP). Pharmacol Biochem Behav 31: 37–41

    Google Scholar 

  • Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136: 1184–1187

    Google Scholar 

  • Goodwin GM, De Souza RJ, Green AR (1985) The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT). Neuropharmacology 24: 1187–1197

    Google Scholar 

  • Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Neuropharmacology 25: 1307–1313

    Google Scholar 

  • Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12: 12–15

    Google Scholar 

  • Higgins GA, Bradbury AJ, Jones BJ, Oakley NR (1988) Behavioural and biochemical activation of 5-HT 1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology 27: 993–1001

    Google Scholar 

  • Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10: 130–132

    Google Scholar 

  • Hutson PH, Donohoe TP, Curzon G (1987) Hypothermia induced by the putative 5-HT 1A agonist LY 165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol 143: 221–228

    Google Scholar 

  • Hutson PH, Sarna GS, O'Connell MT, Curzon G (1988) Decrease of hippocampal 5-HT release following infusion of 8-OH-DPAT into the dorsal raphe. Br J Pharmacol 94: 387 P

  • Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR 38032 F a 5-HT3-receptor antagonist. Br J Pharmacol 93: 985–993

    Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioural effects mediated by central 5-HT 1C receptors. Br J Pharmacol 94: 137–147

    Google Scholar 

  • Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT 1C receptor antagonists. Eur J Pharmacol 164: 445–454

    Google Scholar 

  • Klodzinska A, Jaros T, Cojnacka-Wojcik E, Maj J (1989) Exploratory hypoactivity induced by m-trifluoromethylphenyliperazine (TFMPP) and m-chlorophenylpiperazine (mCPP). J Neural Transm (P-D Sect) 1: 207–218

    Google Scholar 

  • Lecci A, Borsini F, Volterra G, Meli A (1990) Pharmacological validation of a novel model of anticipatory anxiety. Psychopharmacology (in press)

  • Maj J, Chojnacka-Wojcik E, Klodzinska A, Deren A, Moryl E (1988) Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT 1B receptors? J Neural Transm 73: 43–55

    Google Scholar 

  • Mansbach RS, Geyer MA (1988) Blockade of potentiated startle responding in rats by 5- hydroxytryptamine1A receptor ligands. Eur J Pharmacol 156: 375–383

    Google Scholar 

  • Mennini T, Caccia S, Garattini S (1987) Mechanism of action of anxiolytic drugs. Progr Drug Res 31: 315–345

    Google Scholar 

  • Morinan A (1989) Effects of the 5-HT3 receptor antagonists, GR 38032 F and BRL 24924, on anxiety in socially isolated rats. Br J Pharmacol 97: 457 P

  • Pazos A, Hoyer D, Dietl MM, Palacios JM (1988) Autoradiography of serotonin receptors. In: Osborne NN, Hamon M (eds) Neuronal serotonin. John Wiley & Sons, London, pp 507–543

    Google Scholar 

  • Pei Q, Zetterstrom T, Fillenz M (1989) Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology 28: 1061–1066

    Google Scholar 

  • Peroutka SJ (1988) Functional correlates of central 5-HT binding sites. In: Osborne NN, Hamon M (eds) Neuronal serotonin. John Wiley & Sons, London, pp 423–447

    Google Scholar 

  • Sertonin Club Receptor Nomenclature Committee (1990) Receptor nomenclature supplement. Trends Pharmacol Sci 11 [Suppl 16]

  • Sills MA, Barry B, Frazer W, Frazer A (1984) Determination of selective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231: 480–487

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT 1A and 5-HT 1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27: 707–715

    Google Scholar 

  • Taylor DP, Eison MS, Riblet LA, Vandermaelen CP (1985) Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23: 687–694

    Google Scholar 

  • Traber J, Glaser T (1987) 5-HT 1A receptor-related anxiolytics. Trends Pharmacol Sci 8: 432–437

    Google Scholar 

  • Tye NC, Evritt BJ, Iversen SD (1977) 5-Hydroxytryptamine and punishment. Nature 268: 741–743

    Google Scholar 

  • Wise CD, Berger B, Stein L (1972) Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177: 180–183

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lecci, A., Borsini, F., Mancinelli, A. et al. Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice. J. Neural Transmission 82, 219–230 (1990). https://doi.org/10.1007/BF01272765

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01272765

Keywords

Navigation